South Africa's Aspen hit with warning letter chiding the continent's largest drugmaker over sterility issues
Aspen Pharmacare, the largest drugmaker on the African continent, was slammed in a warning letter by the FDA citing sterility issues that could lead to microbial contamination. The write-up follows a September inspection of Aspen's Gqeberha, South Africa, plant, which produces eye drops and other sterile medicines.
Aspen Pharmacare, the largest drugmaker on the African continent, was slammed in a warning letter by the FDA citing sterility issues that could lead to microbial contamination. The write-up follows a September inspection of Aspen's Gqeberha, South Africa, plant, which produces eye drops and other sterile medicines.
